EAGAN, Minn., Oct. 8, 2020 /PRNewswire/ — Recombinetics Inc., a leading gene editing company with platform technology in therapeutics development, today announced that it has merged its efforts with Makana Therapeutics, a leader in the field of xenotransplantation.